VANDA PHARMACEUTICALS INC. (VNDA) Operating income 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) annual operating income history from SEC filings — each fiscal year as reported.
-$151.2MFY2025 · since FY2016: -$18.6M → -$151.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$151.2M | -271.8% |
| FY2024 | -$40.7M | -191.4% |
| FY2023 | -$14.0M | -320.4% |
| FY2022 | $6.3M | -85.0% |
| FY2021 | $42.2M | +54.8% |
| FY2020 | $27.2M | +19.4% |
| FY2019 | $22.8M | +4.9% |
| FY2018 | $21.7M | +228.6% |
| FY2017 | -$16.9M | +9.0% |
| FY2016 | -$18.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice